» Articles » PMID: 29071794

Posttranscriptional Control of Airway Inflammation

Overview
Publisher Wiley
Date 2017 Oct 27
PMID 29071794
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Acute inflammation in the lungs is a vital protective response, efficiently and swiftly eliminating inciters of tissue injury. However, in respiratory diseases characterized by chronic inflammation, such as chronic obstructive pulmonary disease and asthma, enhanced expression of inflammatory mediators leads to tissue damage and impaired lung function. Although transcription is an essential first step in the induction of proinflammatory genes, tight regulation of inflammation requires more rapid, flexible responses. Increasing evidence shows that such responses are achieved by posttranscriptional mechanisms directly affecting mRNA stability and translation initiation. RNA-binding proteins, microRNAs, and long noncoding RNAs interact with messenger RNA and each other to impact the stability and/or translation of mRNAs implicated in lung inflammation. Recent research has shown that these biological processes play a central role in the pathogenesis of several important pulmonary conditions. This review will highlight several posttranscriptional control mechanisms that influence lung inflammation and the known associations of derangements in these mechanisms with common respiratory diseases. WIREs RNA 2018, 9:e1455. doi: 10.1002/wrna.1455 This article is categorized under: RNA in Disease and Development > RNA in Disease RNA Structure and Dynamics > Influence of RNA Structure in Biological Systems RNA Interactions with Proteins and Other Molecules > Protein-RNA Interactions: Functional Implications RNA Turnover and Surveillance > Regulation of RNA Stability.

Citing Articles

Decoding LncRNA in COPD: Unveiling Prognostic and Diagnostic Power and Their Driving Role in Lung Cancer Progression.

Sweef O, Mahfouz R, Tascioglu T, Albowaidey A, Abdelmonem M, Asfar M Int J Mol Sci. 2024; 25(16).

PMID: 39201688 PMC: 11354875. DOI: 10.3390/ijms25169001.


Emerging Roles of Non-Coding RNAs in Childhood Asthma.

Liang J, Liu X, Chen X, Song X, Li W, Huang Y Front Pharmacol. 2022; 13:856104.

PMID: 35656293 PMC: 9152219. DOI: 10.3389/fphar.2022.856104.


PM2.5 Induces the Expression of Inflammatory Cytokines via the Wnt5a/Ror2 Pathway in Human Bronchial Epithelial Cells.

Zou W, Wang X, Hong W, He F, Hu J, Sheng Q Int J Chron Obstruct Pulmon Dis. 2020; 15:2653-2662.

PMID: 33122903 PMC: 7591099. DOI: 10.2147/COPD.S270762.


Long Noncoding RNAs in the Regulation of Asthma: Current Research and Clinical Implications.

Zhu X, Wei Y, Dong J Front Pharmacol. 2020; 11:532849.

PMID: 33013382 PMC: 7516195. DOI: 10.3389/fphar.2020.532849.


lncRNA PCGEM1 strengthens anti-inflammatory and lung protective effects of montelukast sodium in children with cough-variant asthma.

Xu Z, Meng L, Xie Y, Guo W Braz J Med Biol Res. 2020; 53(7):e9271.

PMID: 32520202 PMC: 7296716. DOI: 10.1590/1414-431X20209271.